Back to Anacor Homepage Developing Drug Candidates Through Boron Chemistry
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.
Overview | Management | Board of Directors | Strategic Alliances | Partnering | Contact Us
    About - Management

We are a biopharmaceutical company developing small molecule therapeutics derived from our boron chemistry platform Careers
AN2690

 

David P. Perry
Chief Executive Officer

Karl R. Beutner, M.D., Ph.D.
Senior Vice President and Chief Medical Officer

Christine E. Gray-Smith
Senior Vice President and Chief Financial Officer

Kirk R. Maples, Ph.D.
Senior Vice President, Program Management

Jacob J. Plattner, Ph.D.
Senior Vice President, Research

Irwin A. Heyman, Ph.D.
Vice President, Nonclinical Development

James R. Marconi
Vice President, Finance and Controller